These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease. Goldstein DS; Sullivan P; Cooney A; Jinsmaa Y; Sullivan R; Gross DJ; Holmes C; Kopin IJ; Sharabi Y J Neurochem; 2012 Dec; 123(6):932-43. PubMed ID: 22906103 [TBL] [Abstract][Full Text] [Related]
24. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Lamensdorf I; Eisenhofer G; Harvey-White J; Nechustan A; Kirk K; Kopin IJ Brain Res; 2000 Jun; 868(2):191-201. PubMed ID: 10854571 [TBL] [Abstract][Full Text] [Related]
25. Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde. Lamensdorf I; Eisenhofer G; Harvey-White J; Hayakawa Y; Kirk K; Kopin IJ J Neurosci Res; 2000 May; 60(4):552-8. PubMed ID: 10797558 [TBL] [Abstract][Full Text] [Related]
26. Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease. Goldstein DS; Sullivan P; Cooney A; Jinsmaa Y; Kopin IJ; Sharabi Y J Neurochem; 2015 Apr; 133(1):14-25. PubMed ID: 25645689 [TBL] [Abstract][Full Text] [Related]
27. Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases. Burke WJ; Li SW; Chung HD; Ruggiero DA; Kristal BS; Johnson EM; Lampe P; Kumar VB; Franko M; Williams EA; Zahm DS Neurotoxicology; 2004 Jan; 25(1-2):101-15. PubMed ID: 14697885 [TBL] [Abstract][Full Text] [Related]
28. The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases. Goldstein DS Semin Neurol; 2020 Oct; 40(5):502-514. PubMed ID: 32906170 [TBL] [Abstract][Full Text] [Related]
29. Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease. Jinsmaa Y; Florang VR; Rees JN; Mexas LM; Eckert LL; Allen EM; Anderson DG; Doorn JA Chem Biol Interact; 2011 Jun; 192(1-2):118-21. PubMed ID: 21238438 [TBL] [Abstract][Full Text] [Related]
34. Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction. Kao CY; Xu M; Wang L; Lin SC; Lee HJ; Duraine L; Bellen HJ; Goldstein DS; Tsai SY; Tsai MJ PLoS Genet; 2020 Jun; 16(6):e1008868. PubMed ID: 32579581 [TBL] [Abstract][Full Text] [Related]
35. Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein. Werner-Allen JW; DuMond JF; Levine RL; Bax A Angew Chem Int Ed Engl; 2016 Jun; 55(26):7374-8. PubMed ID: 27158766 [TBL] [Abstract][Full Text] [Related]
36. Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease. Wey MC; Fernandez E; Martinez PA; Sullivan P; Goldstein DS; Strong R PLoS One; 2012; 7(2):e31522. PubMed ID: 22384032 [TBL] [Abstract][Full Text] [Related]
37. Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine. Burke WJ; Kumar VB; Pandey N; Panneton WM; Gan Q; Franko MW; O'Dell M; Li SW; Pan Y; Chung HD; Galvin JE Acta Neuropathol; 2008 Feb; 115(2):193-203. PubMed ID: 17965867 [TBL] [Abstract][Full Text] [Related]
38. Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo. Vecchio LM; Sullivan P; Dunn AR; Bermejo MK; Fu R; Masoud ST; Gregersen E; Urs NM; Nazari R; Jensen PH; Ramsey A; Goldstein DS; Miller GW; Salahpour A J Neurochem; 2021 Aug; 158(4):960-979. PubMed ID: 33991113 [TBL] [Abstract][Full Text] [Related]
39. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde. Lima VA; do Nascimento LA; Eliezer D; Follmer C ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158 [TBL] [Abstract][Full Text] [Related]